About Sarissa Capital
It is primarily based in Los Angeles, United States.
Key Metrics
Location
Los Angeles, United States
Sarissa Capital's Portfolio
Sarissa Capital News
•
Amyloidosis biotech Attralus scores $116M for handful of treatments, imaging agentFierce Biotech•Sep 08, 2021•Attralus, Logos, VenBio, Janus Henderson Investors and 5 others
